Abstract:Chronic hepatitis B virus (HBV) infection remains a leading cause of hepatic inflammation and damage. The pathogenesis of chronic hepatitis B (CHB) infection is predominantly mediated by persistent intrahepatic immunopathology. With the characterization of unique anatomical and immunological structure, the liver is also deemed an immunological organ, which gives rise to massive cytokines and chemokines under pathogenesis conditions, having significant implications for the progression of HBV infection. The intrahepatic innate immune system is responsible for the formidable source of cytokines and chemokines, with the latter also derived from hepatic parenchymal cells. In addition, systemic cytokines and chemokines are disturbed along with the disease course. Since HBV is a stealth virus, persistent exposure to HBV-related antigens confers to immune exhaustion, whereby regulatory cells are recruited by intrahepatic chemokines and cytokines, including interleukin-10 and transforming growth factor β, are involved in such series of causal events. Although the considerable value of two types of available approved treatment, interferons and nucleos(t)ide analogues, effectively suppress HBV replication, neither of them is sufficient for optimal restoration of the immunological attrition state to win the battle of the functional or virological cure of CHB infection. Notably, cytokines and chemokines play a crucial role in regulating the immune response. They exert effects by directly acting on HBV or indirectly manipulating target immune cells. As such, specific cytokines and chemokines, with a potential possibility to serve as novel immunological interventions, combined with those that target the virus itself, seem to be promising prospects in curative CHB infection. Here, we systematically review the recent literature that elucidates cytokine and chemokine-mediated pathogenesis and immune exhaustion of HBV infection and their dynamics triggered by current mainstream anti-HBV therapy. The predictive value of disease progression or control and the immunotherapies target of specific major cytokines and chemokines in CHB infection will also be delineated.

The Functions of Hepatitis B Virus Encoding Proteins: Viral Persistence and Liver Pathogenesis

Cytokines and Chemokines in HBV Infection

Mechanisms of Hepatitis B Virus Persistence

Pathogenicity and virulence of Hepatitis B virus

Progress of Infection and Replication Systems of Hepatitis B Virus

Hepatitis B Virus-Persistent Infection and Innate Immunity Defect: Cell-related or Virus-Related?

HBV Genome and Life Cycle

HBsAg, Subviral Particles, and Their Clearance in Establishing a Functional Cure of Chronic Hepatitis B Virus Infection.

Hepatitis B virus entry, assembly, and egress

The role of HBV-induced autophagy in HBV replication and HBV related-HCC

The immune mechanism of chronic hepatitis B virus persistent infection

B Lymphocyte-Mediated Humoral Immunity in the Pathogenesis of Chronic Hepatitis B Infection

Hepatitis B virus persistence and reactivation

Role of hepatitis B virus non-structural protein HBx on HBV replication, interferon signaling, and hepatocarcinogenesis

[The Clinical Significance and Mechanism of the Effect for Hepatitis B Virus Protein on Host Immune].

Innate and Adaptive Immune Escape Mechanisms of Hepatitis B Virus

The Role Of Immune Cells In Chronic Hbv Infection

New Insights into Hepatitis B Virus Biology and Implications for Novel Antiviral Strategies

Immunobiology and pathogenesis of hepatitis B virus infection

The novel mechanism facilitating chronic hepatitis B infection: immunometabolism and epigenetic modification reprogramming

Hepatitis B virus pathogenesis: Fresh insights into hepatitis B virus RNA